BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

524 related articles for article (PubMed ID: 19532014)

  • 21. Cutaneous T cell lymphoma-mycosis fungoides and Sezary syndrome: an update.
    Parker SR; Bethaney JV
    G Ital Dermatol Venereol; 2009 Aug; 144(4):467-85. PubMed ID: 19755952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Controversies in the management of the cutaneous T cell lymphomas.
    Zic JA
    Dermatol Ther; 2009; 22(5):407-17. PubMed ID: 19845718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapy options in cutaneous T-cell lymphoma.
    Apisarnthanarax N; Duvic M
    Expert Rev Anticancer Ther; 2001 Oct; 1(3):403-20. PubMed ID: 12113107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bexarotene therapy for mycosis fungoides and Sézary syndrome.
    Abbott RA; Whittaker SJ; Morris SL; Russell-Jones R; Hung T; Bashir SJ; Scarisbrick JJ
    Br J Dermatol; 2009 Jun; 160(6):1299-307. PubMed ID: 19222457
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent advances in primary cutaneous T-cell lymphoma.
    DeSimone JA; Sodha P; Ignatova D; Dummer R; Cozzio A; Guenova E
    Curr Opin Oncol; 2015 Mar; 27(2):128-33. PubMed ID: 25594623
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of maintenance phototherapy in cutaneous T-cell lymphoma.
    Pothiawala SZ; Baldwin BT; Cherpelis BS; Glass LF; Fenske NA
    J Drugs Dermatol; 2010 Jul; 9(7):800-3. PubMed ID: 20677536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Malignant lymphoma of the skin].
    Nakajima H; Miyamoto H
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1735-43. PubMed ID: 3876074
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of cutaneous T-cell lymphoma.
    Zackheim HS
    Semin Dermatol; 1994 Sep; 13(3):207-15. PubMed ID: 7986690
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ECP versus PUVA for the treatment of cutaneous T-cell lymphoma.
    Geskin L
    Skin Therapy Lett; 2007 Jun; 12(5):1-4. PubMed ID: 17609808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cutaneous T-cell lymphoma: overview and nursing perspectives.
    McCann SA
    Nurs Clin North Am; 2007 Sep; 42(3):421-55, vi-vii. PubMed ID: 17825663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cutaneous T-cell lymphoma.
    Gemmill R
    Semin Oncol Nurs; 2006 May; 22(2):90-6. PubMed ID: 16720231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Monitoring the decrease of circulating malignant T cells in cutaneous T-cell lymphoma during photopheresis and interferon therapy.
    Ferenczi K; Yawalkar N; Jones D; Kupper TS
    Arch Dermatol; 2003 Jul; 139(7):909-13. PubMed ID: 12873887
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Palliative total skin electron beam therapy (TSEBT) for advanced cutaneous T-cell lymphoma.
    Funk A; Hensley F; Krempien R; Neuhof D; Van Kampen M; Treiber M; Roeder F; Timke C; Herfarth K; Helmbold P; Debus J; Bischof M
    Eur J Dermatol; 2008; 18(3):308-12. PubMed ID: 18474461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are we there yet? cellular therapies for cutaneous T cell lymphoma.
    Atilla PA; Atilla E
    Curr Res Transl Med; 2023; 71(2):103390. PubMed ID: 37062252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pruritus in cutaneous T-cell lymphomas: frequent, often severe and difficult to treat.
    Meyer N; Paul C; Misery L
    Acta Derm Venereol; 2010; 90(1):12-7. PubMed ID: 20107719
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systemic therapy of cutaneous T-cell lymphoma (CTCL).
    Alpdogan O; Kartan S; Johnson W; Sokol K; Porcu P
    Chin Clin Oncol; 2019 Feb; 8(1):10. PubMed ID: 30818958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic approaches in cutaneous lymphoma.
    Jörg B; Kerl H; Thiers BH; Bröcker EB; Burg G
    Dermatol Clin; 1994 Apr; 12(2):433-41. PubMed ID: 8045054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cutaneous T-cell lymphoma.
    Gilyon K; Kuzel TM
    Oncol Nurs Forum; 1991 Jul; 18(5):901-8. PubMed ID: 1891419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stem cell transplantation in advanced cutaneous T-cell lymphoma.
    Introcaso CE; Leber B; Greene K; Ubriani R; Rook AH; Kim EJ
    J Am Acad Dermatol; 2008 Apr; 58(4):645-9. PubMed ID: 18258335
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vorinostat for treatment of cutaneous manifestations of advanced primary cutaneous T-cell lymphoma.
    Mann BS; Johnson JR; He K; Sridhara R; Abraham S; Booth BP; Verbois L; Morse DE; Jee JM; Pope S; Harapanhalli RS; Dagher R; Farrell A; Justice R; Pazdur R
    Clin Cancer Res; 2007 Apr; 13(8):2318-22. PubMed ID: 17438089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.